Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity

Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity

Bibliographic Details
Main Authors:	Gasperikova, D, Tribble, N, Stanik, J, Huckova, M, Misovicova, N, van de Bunt, M, Kuklisova, L, Barrow, B, Barak, L, Dobransky, R, Bereczkova, E, Colclough, K, Ellard, S, Klimes, I, Gloyn, A
Format:	Conference item
Published:	2008

Similar Items

Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
by: Gasperíková, D, et al.
Published: (2009)

Identification of a Novel beta-Cell Glucokinase (GCK) Promoter Mutation (-71G > C) That Modulates GCK Gene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in Humans
by: Gasperikova, D, et al.
Published: (2009)

Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
by: Valentinova, L, et al.
Published: (2011)

Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
by: Gloyn, A, et al.
Published: (2008)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
by: Valentinova, L, et al.
Published: (2012)

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
by: Gloyn, A, et al.
Published: (2007)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
by: Thomson, K, et al.
Published: (2003)

Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
by: Christesen, H, et al.
Published: (2008)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
by: Osbak, K, et al.
Published: (2009)

Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
by: Turkkahraman, D, et al.
Published: (2008)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
by: Gloyn, A
Published: (2003)

Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia
by: Beer, N, et al.
Published: (2010)

Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia.
by: Gloyn, A, et al.
Published: (2009)

Familial persistent hyperinsulinaemic hypoglycaemia of infancy due to a novel glucokinase (GCK) activating mutation G68V
by: Gloyn, A, et al.
Published: (2006)

Phenotypic heterogeneity in a family with a novel activating glucokinase (GCK) mutation (G68V) causing familial persistent hyperinsulinaemic hypoglycaemia of infancy
by: Gloyn, A, et al.
Published: (2007)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY.
by: Steele, A, et al.
Published: (2011)

The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY
by: Steele, A, et al.
Published: (2011)

Insulin resistance and intrauterine growth retardation due to a novel balanced translocation (46,t(7;19)(p15.2;p13.2)) which disrupts the insulin receptor (INSR) gene
by: Suliman, S, et al.
Published: (2007)

Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans.
by: van de Bunt, M, et al.
Published: (2008)

Dairy Product Consumption Interacts with Glucokinase (GCK) Gene Polymorphisms Associated with Insulin Resistance
by: Marine S. Da Silva, et al.
Published: (2017-08-01)

Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
by: Beer, N, et al.
Published: (2011)

Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
by: Li, Xiuzhen, et al.
Published: (2018)

The phenotypic severity of homozygous GCK mutations causing neonatal or adolescent-onset diabetes is mediated through thermostability in addition to enzyme activity
by: Chakera, A, et al.
Published: (2014)

Insulin resistance and intrauterine growth retardation due to a novel balanced translocation [46,t (7;19) (p15.2;p13.2)1 which disrupts the insulin receptor gene
by: Suliman, S, et al.
Published: (2007)

Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism.
by: Suliman, S, et al.
Published: (2009)

Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
by: Ding, S, et al.
Published: (2010)

Functional characterisation of the glucokinase regulatory protein gene variant P446L shows diminished regulation by fructose-6 phosphate resulting in increased glucokinase activity
by: Beer, N, et al.
Published: (2009)

Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability.
by: Raimondo, A, et al.
Published: (2014)

Investigating novel mutational mechanisms for glucokinase mutations with near normal or paradoxical kinetics
by: Tribble, N, et al.
Published: (2009)

Insights into the pathogenicity of rare missense GCK variants from the identification and functional characterization of compound heterozygous and double mutations inherited in cis.
by: Beer, N, et al.
Published: (2012)

Non-immune diabetes mellitus in children due to heterozygous mutations in the glucokinase gene (GCK-MODY): data of 144 patients
by: E. A. Sechko, et al.
Published: (2022-05-01)

Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
by: Gloyn, A, et al.
Published: (2002)

Atypical phenotype associated with reported GCK exon 10 deletions: Clinical judgement is needed alongside appropriate genetic investigations.
by: Thanabalasingham, G, et al.
Published: (2013)

Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.
by: Wabitsch, M, et al.
Published: (2007)

Insights into biochemical and genetical basis of glucokinase activation from naturally occuring hypoglycaemia mutations
by: Gloyn, A, et al.
Published: (2003)

GCK exonic mutations induce abnormal biochemical activities and result in GCK-MODY
by: Tongtong Dai, et al.
Published: (2023-04-01)

Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment
by: S Schnyder, et al.
Published: (2005-06-01)

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
by: Gloyn, A, et al.
Published: (2003)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
by: Rees, MG, et al.
Published: (2014)

Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?
by: Rees, MG, et al.
Published: (2014)